Emerging role of competing endogenous RNA and associated noncoding RNAs in thyroid cancer

Qian Bai1,2, Zhenjie Pan1, Ghulam Nabi3

  • 1Department of Anesthesiology, The Second Affiliated Hospital of Zhengzhou University Zhengzhou 450000, Henan, China.

Insights

Regulatory interactions among non-coding RNAs (ncRNAs) are crucial in thyroid cancer. Competing endogenous RNA (ceRNA) networks, involving long non-coding RNAs (lnRNAs), pseudogenes, and microRNAs (miRNAs), are implicated in thyroid cancer progression and drug resistance.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Thyroid cancer is the most common endocrine malignancy, with limited treatment options for certain types.
  • Understanding thyroid cancer's multistep carcinogenesis is vital for developing effective treatment strategies.
  • Non-coding RNAs (ncRNAs) are increasingly linked to thyroid cancer progression, but their regulatory interactions are not fully understood.

Purpose of the Study:

  • To review the emerging roles of competing endogenous RNA (ceRNA) members in thyroid cancer.
  • To summarize current knowledge on ceRNA networks, including long non-coding RNAs (lnRNAs), pseudogenes, and microRNAs (miRNAs), in thyroid cancer.

Main Methods:

  • Literature review of studies investigating ncRNAs and ceRNA networks in thyroid cancer.
  • Analysis of regulatory interactions among pseudogenes, lnRNAs, circular RNAs (circRNAs), and miRNAs.
  • Examination of ceRNA deregulation in thyroid cancer development, invasion, metastasis, epithelial-mesenchymal transition (EMT), and drug resistance.

Main Results:

  • ceRNA networks are deregulated in thyroid cancer development, invasion, and metastasis.
  • ceRNA deregulation is associated with epithelial-mesenchymal transition (EMT) and drug resistance in thyroid cancer.
  • Numerous ceRNA networks play significant roles in various aspects of thyroid cancer progression.

Conclusions:

  • Understanding ceRNA network deregulation is crucial for developing early diagnostic markers and effective therapeutic strategies for thyroid cancer.
  • Further research into novel ceRNA members and their interactions can advance thyroid cancer treatment.
  • ceRNA mechanisms offer promising avenues for improving thyroid cancer management and patient outcomes.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.3K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
6.6K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.1K